BioAge Labs, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue -7.79M-2.37M
Cost of Revenue 15.89M37.13M
Operating items
Research & Development 33.89M59.04M
Selling, General & Administrative 14.51M19.16M
Operating Expenses 48.40M78.19M
Operating Income -48.40M-78.19M
EBIT -48.40M-78.19M
Non-operating items
Interest & Investment Income 2.43M9.63M
Other Non Operating Income -0.25M
Non Operating Income -15.45M7.08M
Net income details
EBT -53.76M-70.93M
Profit After Tax -63.85M-71.11M
Income from Continuing Operations -53.76M-70.93M
Consolidated Net Income -53.76M-70.93M
Income towards Parent Company -53.76M-70.93M
Net Income towards Common Stockholders -53.76M-70.93M
Additional items
EPS (Basic) -38.17-6.63
EPS (Weighted Average and Diluted) -38.17-6.63
Shares Outstanding (Weighted Average) 33.67M35.85M
EBITDA -63.86M-71.03M
Interest Expenses 7.79M2.37M